The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 4,839 | 355,785 | SH | SOLE | 355,785 | 0 | 0 | ||
| ANTHEM INC | COM | 036752103 | 46,351 | 161,512 | SH | SOLE | 161,512 | 0 | 0 | ||
| CENTENE CORP DEL | COM | 15135B101 | 29,076 | 547,575 | SH | SOLE | 547,575 | 0 | 0 | ||
| HCA HEALTHCARE INC | COM | 40412C101 | 20,758 | 159,213 | SH | SOLE | 159,213 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 4,058 | 166,024 | SH | SOLE | 166,024 | 0 | 0 | ||
| LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 47,505 | 310,530 | SH | SOLE | 310,530 | 0 | 0 | ||
| MEDPACE HLDGS INC | COM | 58506Q109 | 7,483 | 126,887 | SH | SOLE | 126,887 | 0 | 0 | ||
| MOLINA HEALTHCARE INC | COM | 60855R100 | 23,972 | 168,867 | SH | SOLE | 168,867 | 0 | 0 | ||
| PATTERSON COMPANIES INC | COM | 703395103 | 11,145 | 510,054 | SH | SOLE | 510,054 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 2,285 | 100,985 | SH | SOLE | 100,985 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 19,392 | 144,968 | SH | SOLE | 144,968 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 48,498 | 379,777 | SH | SOLE | 379,777 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 5,981 | 108,734 | SH | SOLE | 108,734 | 0 | 0 | ||